Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Dr Valeria Ricotti
Dr Valeria Ricotti profile picture
  • Honorary Lecturer
  • UCL GOS Institute of Child Health
  • Faculty of Pop Health Sciences

Research Themes
Research Summary

Originally from Italy, I graduated with honours from RCSI, Ireland. In Dublin I completed my core paediatric training. At the beginning of 2010 I joined the Dubowitz Neuromuscular Centre, at the UCL Institute of Child Health and Great Ormond Street Hospital. I worked as a clinical researcher and investigator for numerous clinical trials for neuromuscular disorders, including the EU funded Skip-NMD project on antisense oligomer exon skipping (http://www.skip-nmd.eu), led by Professor Francesco Muntoni. I completed my higher degree focused on characterising the evolving natural history of Duchenne muscular dystrophy (DMD) and developing novel outcome measures for clinical trials. 


As part of my research projects I reported on the use, benefits and adverse effects of glucocorticoids in large cohorts of DMD subjects, and further delineated their cognitive and neurobehavioral profile in relation to their underlying genotype. I initiated collaborative efforts to deepen our understanding of the relationship between genotype and phenotype in DMD.  I have been an active member of international consortia, which developed new biomarkers and clinical outcome measures for neuromuscular disorders including activity monitors, myometers, functional scales and muscle MR imaging. I acted as a consultant for the Institute of Myology, University of Pierre et Marie Curie-Sorbonne, Paris.


With the goal to develop new pharmaco-gene therapies, I joined industry as Medical Director for the neuromuscular franchise of BioMarin Pharmaceutical Inc. Subsequently, I worked at Solid Biosciences as Director of Translational Research and Development, with a focus on the AAV-delivered micro-dystrophin gene therapy programme for DMD and the development of novel biomarkers.  

As an Honorary Lecturer at the Great Ormond Street Institute of Child Health I remain involved in academic research and notably in developing new technologies leveraging artificial intelligence and machine learning for monitoring neuromuscular diseases in children.


In April 2019 I co-founded DiNAQOR AG, a gene therapy biotech focused on advancing novel solutions for children and adults suffering from monogenic Cardiomyopathies (www.dinaqor.com). At DiNAQOR I currently hold a position as Executive Vice President and Chief Medical Officer. 

Teaching Summary

Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by